MENU
PBPH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PBPH stock forecast, quote, news & analysis

The investment seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index... Show more

Category: #Health
PBPH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PBPH with price predictions
Aug 21, 2026

Momentum Indicator for PBPH turns positive, indicating new upward trend

PBPH saw its Momentum Indicator move above the 0 level on August 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator turned positive. In of the 13 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PBPH just turned positive on August 10, 2026. Looking at past instances where PBPH's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBPH advanced for three days, in of 33 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 25 cases where PBPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PBPH broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE).

Industry description

The investment seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index. The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.

Market Cap

The average market capitalization across the Portfolio Bldg Blck Wld Phrm &BtchIdxETF ETF is 388.14B. The market cap for tickers in the group ranges from 3.51M to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is NOVN at 3.51M.

High and low price notable news

The average weekly price growth across all stocks in the Portfolio Bldg Blck Wld Phrm &BtchIdxETF ETF was 12%. For the same ETF, the average monthly price growth was 22%, and the average quarterly price growth was 27%. MRK experienced the highest price growth at 12%, while ROP experienced the biggest fall at 3%.

Volume

The average weekly volume growth across all stocks in the Portfolio Bldg Blck Wld Phrm &BtchIdxETF ETF was 53%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 21
P/E Growth Rating: 47
Price Growth Rating: 23
SMR Rating: 38
Profit Risk Rating: 32
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
PBPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
United States
Phone
N/A
Web
N/A
Momentum Indicator for PBPH turns positive, indicating new upward trend